π #SimInSitu Update!
Weβre closing the year with 10 peer-reviewed publications on THV testing and patient-specific modeling!
In 2025, expect more on:
β Tissue regeneration
β FSI modeling
β VVUQ (ASME V&V 40)
Excited for whatβs next! π¬
#Innovation#VVUQ#FSI#H2020
Exciting progress in the H2020 #SimInSitu project!
We validated a patient-specific TAVI model for testing tissue-engineered heart valves (THVs), achieving <10% error in structural predictions. This sets the stage for evaluating Xeltis' biodegradable TAVI device! π
#TAVI
Milestone #8 achieved! The Sapien-3 ETR heart valve model is now verified and validated within the SimInSitu project. Using in-silico methods and validated components, weβre pushing innovation in valve design. Sensitivity & uncertainty analyses add robustness. #SimInSitu
Excited to announce Milestone #15: successful patient-specific modeling of tissue-engineered heart valves in young patients! #medicalinnovation#milestone
Collaborated at #KU_Leuven and #EMSE to model #Xeltis carotid conduit's tissue growth and remodeling. Translated animal trial data to a computational model, capturing tissue adaptation and scaffold degradation. Exciting steps at #H2020 project
At TU-Graz, our research group just released two groundbreaking papers on electrospun polymers for Xeltis' heart valves. These studies tackle complex biomechanical issues and provide valuable insights. Dive in looking at our Newsletter: https://t.co/sJRwlpeKmK
Developing a non-invasive approach to estimate patient-specific material properties for individuals undergoing #TAVI. This innovative approach relies on #FEA modeling and dynamic CT imaging data to minimize discrepancies between FEAs and actual CT shapes #H2020,
4RealSim, as the SimInSitu - In-silico Development- and Clinical-Trial-Platform Consortium leader, is excited to share with you the invitation to the INNOVAHEART workshop.
This event is organized by our fellow SimCardioTest EU project eHealth_EU consortβ¦https://t.co/EQJO3vSohC
Save the date: 22 March 2023 in Bordeaux, France.
For the first time, five EU funded projects join their forces to bring together different actors of the #insilico#cardiovascular ecosystem, during a one-day workshop.
more information on: https://t.co/vXb8aHpUAz
The MS2 milestone successfully concludes the scaffold characterisation and Uncertainty Quantification (Epistemic and Aleatoric uncertainty) of three scaffold materials used in Xeltis for in-situ tissue-engineered heart valves in WP1
#VPH2022 is great science, hands-on workshops, student activities, community and networking... all of this in the amazing setting of one of the most charming cities of Portugal: Porto ππ·π―
We are waiting for you there!